MBOT (Microbot Medical) FCF Margin %: -4,915.24% (As of Mar. 2026)


MBOT Microbot Medical Inc MBOT
24 GF Score
Price $1.78
! 2 Warning Signs
View Full Analysis

What is Microbot Medical FCF Margin %?

Microbot Medical MBOT -1.11% 24 FCF Margin % is -4,915.24% as of Mar. 2026. GuruFocus rates MBOT with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Microbot Medical ranks worse than 98.77% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Microbot Medical's Free Cash Flow for the three months ended in Mar. 2026 was $-5.16 Mil. Microbot Medical's Revenue for the three months ended in Mar. 2026 was $0.11 Mil. Therefore, Microbot Medical's FCF Margin % for the quarter that ended in Mar. 2026 was -4,915.24%.

As of today, Microbot Medical's current FCF Yield % is -12.90%.

The historical rank and industry rank for Microbot Medical's FCF Margin % or its related term are showing as below:

MBOT' s FCF Margin % Range Over the Past 10 Years
Min: -14647.62   Med: 0   Max: 0
Current: -14647.62

MBOT's FCF Margin % is ranked worse than
98.77% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs MBOT: -14647.62

Microbot Medical FCF Margin % Related Terms

Microbot Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Microbot Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical FCF Margin % Chart

Microbot Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Microbot Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -4,915.24

MBOT vs KRMD, STXS, EMBC: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbot Medical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Microbot Medical's FCF Margin % falls into.


MBOT
24GF Score
Microbot Medical Inc MBOT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbot Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Microbot Medical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.106/0
= %

Microbot Medical's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.161/0.105
=-4,915.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -4,915.24% mean?
Microbot Medical (MBOT) has a FCF Margin % of -4,915.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Microbot Medical and its competitors. According to the industry distribution chart, Microbot Medical ranks #805 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 98.8%.
Is Microbot Medical's FCF Margin % too high?
Microbot Medical's current FCF Margin % is -4,915.24%. Based on the distribution chart, Microbot Medical ranks #805 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Microbot Medical has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's FCF Margin % compare to KRMD and STXS?
According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #805 out of 815 companies for FCF Margin %. This places Microbot Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Microbot Medical and its competitors. Microbot Medical's current FCF Margin % is -4,915.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (MBOT) has a current FCF Margin % of -4,915.24%. The current FCF Margin % is -4,915.24%. Microbot Medical's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Microbot Medical (MBOT), the current FCF Margin % is -4,915.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Other Exchanges CY9D:Germany
Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
24GF Score

Get the complete analysis for MBOT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.78
Price